Stemler J, Yeghiazaryan L, Stephan C, Mohn KG, et al. Immunogenicity, reactogenicity and safety of a second booster with BNT162b2 or full-dose mRNA-1273: a randomised VACCELERATE trial in adults >/=75 years (EU-COVAT-1-AGED Part B). Int J Infect Dis 2024 Jul 9:107161. doi: 10.1016/j.ijid.2024.107161.
PMID: 38992789